Gold-facilitated in situ hybridization: a bright-field autometallographic alternative to fluorescence in situ hybridization for detection of Her-2/neu gene amplification.
作者： Raymond Tubbs , James Pettay , Marek Skacel , Richard Powell , Mark Stoler
DOI: 10.1016/S0002-9440(10)61106-6
关键词: Microscopy 、 Bright-field microscopy 、 Fluorescence in situ hybridization 、 In situ 、 Gene duplication 、 In situ hybridization 、 Immunohistochemistry 、 Biology 、 Gene expression 、 Molecular biology
摘要: … The method is summarized in Figure 1. Unstained 4-μm paraffin sections on electrostatically … Gold ions in solution are catalytically deposited onto the Nanogold particle as metallic gold (…
elsevier.com
sci-hub.se 参考文章(41)
Gabriel Hortobagyi, Jae Y. Ro, Mark Blick, Debra Frye, Herbert Fritsche, Jungsil Ro, Adel K El-Naggar, Giuseooe Fraschini, c-erbB-2 Amplification in Node-negative Human Breast Cancer Cancer Research. ,vol. 49, pp. 6941- 6944 ,(1989)
Raymond R. Tubbs, James Pettay, Pat Roche, Mark H. Stoler, Robert Jenkins, Jon Myles, Thomas Grogan, Concomitant Oncoprotein Detection with Fluorescence in Situ Hybridization (CODFISH): A Fluorescence-Based Assay Enabling Simultaneous Visualization of Gene Amplification and Encoded Protein Expression The Journal of Molecular Diagnostics. ,vol. 2, pp. 78- 83 ,(2000) , 10.1016/S1525-1578(10)60620-4
Godolphin W, Pauletti G, Press Mf, Slamon Dj, Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene. ,vol. 13, pp. 63- 72 ,(1996)
B A Gusterson, R D Gelber, A Goldhirsch, K N Price, J Säve-Söderborgh, R Anbazhagan, J Styles, C M Rudenstam, R Golouh, R Reed, Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. Journal of Clinical Oncology. ,vol. 10, pp. 1049- 1056 ,(1992) , 10.1200/JCO.1992.10.7.1049
M F Press, L Bernstein, P A Thomas, L F Meisner, J Y Zhou, Y Ma, G Hung, R A Robinson, C Harris, A El-Naggar, D J Slamon, R N Phillips, J S Ross, S R Wolman, K J Flom, HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. Journal of Clinical Oncology. ,vol. 15, pp. 2894- 2904 ,(1997) , 10.1200/JCO.1997.15.8.2894
John Bernard Henry, Clinical diagnosis and management by laboratory methods ,(1979)
R.R. Tubbs, J.D. Pettay, P.C. Roche, M.H. Stoler, R.B. Jenkins, T.M. Grogan, Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy: Apparent Immunohistochemical False-Positives Do Not Get the Message Journal of Clinical Oncology. ,vol. 19, pp. 2714- 2721 ,(2001) , 10.1200/JCO.2001.19.10.2714
S Toikkanen, H Helin, J Isola, H Joensuu, Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. Journal of Clinical Oncology. ,vol. 10, pp. 1044- 1048 ,(1992) , 10.1200/JCO.1992.10.7.1044
Joan Albanell, Larry Norton, Jose Baselga, Young Mee Kim, John Mendelsohn, Recombinant Humanized anti-HER2 Antibody (Herceptin) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin Against HER2/neu Overexpressing Human Breast Cancer Xenografts Cancer Research. ,vol. 58, pp. 2825- 2831 ,(1998)
Ann D. Thor, Donald A. Berry, Daniel R. Budman, Hyman B. Muss, Timothy Kute, I. Craig Henderson, Maurice Barcos, Constance Cirrincione, Susan Edgerton, Craig Allred, Larry Norton, Edison T. Liu, erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer Journal of the National Cancer Institute. ,vol. 90, pp. 1346- 1360 ,(1998) , 10.1093/JNCI/90.18.1346